Drug Type Small molecule drug |
Synonyms 9,11-dehydrocortexolone 17alpha-butyrate |
Target |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H34O5 |
InChIKeyIMSKTQNPYUKZMB-AMMWCUJOSA-N |
CAS Registry872623-99-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | IT | 31 Dec 2005 | |
Prostatic Hyperplasia | Preclinical | IT | 31 Dec 2005 |